Results 101 to 110 of about 7,260 (206)

Omidenepag Isopropyl Versus Latanoprost in Primary Open-angle Glaucoma and Ocular Hypertension: ThePhase 3 AYAME Study.

American journal of ophthalmology-glaucoma, 2020
M. Aihara, Fenghe Lu, Hisashi Kawata, Akihiro Iwata, Noriko Odani-Kawabata, Naveed B. K. Shams   +5 more
semanticscholar   +1 more source

A study of the safety and efficacy of travoprost 0.004%/timolol 0.5% ophthalmic solution compared to latanoprost 0.005% and timolol 0.5% dosed concomitantly in patients with open-angle glaucoma or ocular hypertension

Clinical Ophthalmology, 2008
Douglas J Rhee1, James H Peace2, Sushanta Mallick3, Theresa A Landry3, Michael VW Bergamini3, and the Study Group*1Massachusetts Eye and Ear Infirmary, Harvard University, Boston, MA, USA; 2Diabetic Eye Medical Clinic, Inglewood, CA, USA; 3Alcon ...
Douglas J Rhee, James H Peace, Sushanta Mallick, Theresa A Landry, Michael VW Bergamini, the Study Group*   +5 more
doaj  

Latanoprost ophthalmic solution in the treatment of open angle glaucoma or raised intraocular pressure: a review

Clinical Ophthalmology, 2009
Andrea Russo, Ivano Riva, Teodoro Pizzolante, Federico Noto, Luciano QuarantaCattedra di Malattie dell’Apparato Visivo, Università degli studi di Brescia, USVD “Centro per lo studio del Glaucoma” Spedali Civili di
Andrea Russo, Ivano Riva, Teodoro Pizzolante, Federico Noto, Luciano Quaranta   +4 more
doaj  

Differential activity and clinical utility of latanoprost in glaucoma and ocular hypertension

Clinical Ophthalmology, 2012
Fernanda Pacella, Paolo Turchetti, Valentina Santamaria, David Impallara, Gianpaolo Smaldone, Chiara Brillante, Aloisa Librando, Angela Damiano, Jose Pecori-Giraldi, Elena PacellaDepartment of Sense Organs, University of Rome "Sapienza ...
Pacella F, Turchetti P, Santamaria V, Impallara D, Smaldone G, Brillante C, Librando A, Damiano A, Pecori-Giraldi J, Pacella E   +8 more
doaj  

Intraocular pressure and visual field changes in normal-tension glaucoma patients treated using either unoprostone or latanoprost: a prospective comparative study

Clinical Ophthalmology, 2017
Daisuke Takemoto, Tomomi Higashide, Yoshiaki Saito, Shinji Ohkubo, Sachiko Udagawa, Hisashi Takeda, Kazuhisa Sugiyama Department of Ophthalmology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan Purpose: We conducted a ...
Takemoto D, Higashide T, Saito Y, Ohkubo S, Udagawa S, Takeda H, Sugiyama K   +6 more
doaj  

Efficacy and safety of switching to latanoprost 0.005%–timolol maleate 0.5% fixed-combination eyedrops from an unfixed combination for 36 months

Clinical Ophthalmology, 2014
Kenji Inoue,1 Ryoko Okayama,1 Risako Higa,1 Goji Tomita2 1Inouye Eye Hospital, Tokyo, 2Second Department of Ophthalmology, Toho University School of Medicine, Tokyo, Japan Purpose: We prospectively investigated the intraocular pressure (IOP)-reducing ...
Inoue K, Okayama R, Higa R, Tomita G
doaj  

Drug-related macular edema: a real-world FDA Adverse Event Reporting System database study. [PDF]

BMC Pharmacol Toxicol
Li X, Sun YQ, Huang QL, Zhang ZJ, Shi LQ, Tang JF, Luo ZY.   +6 more
europepmc   +1 more source

Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial

The Lancet, 2015
D. Garway-Heath, D. Crabb, C. Bunce, G. Lascaratos, F. Amalfitano, N. Anand, A. Azuara-Blanco, R. Bourne, D. Broadway, I. Cunliffe, J. Diamond, S. Fraser, T. Ho, K. Martin, A. McNaught, A. Negi, Krishna Patel, Richard A. Russell, Ameet Shah, P. Spry, Katsuyoshi Suzuki, E. White, R. Wormald, W. Xing, T. Zeyen   +24 more
semanticscholar   +1 more source

Challenging glaucoma with emerging therapies: an overview of advancements against the silent thief of sight. [PDF]

Front Med (Lausanne)
Sarkis S, Chamard C, Johansen B, Daien V, Michon F.   +4 more
europepmc   +1 more source

Effects of Brimonidine, Latanoprost, and Omidenepag on Tunicamycin-Induced Endoplasmic Reticulum Stress and Fibrosis in Human Trabecular Meshwork Cells. [PDF]

Biomolecules
Liu M, Honjo M, Yamagishi R, Aihara M.
europepmc   +1 more source